Illuminating public buildings in red, candlelight vigils, and walks are among events planned for World Sickle Cell Day, June ...

In honor of this year's World Sickle Cell Day, columnist Dunstan Nicol-Wilson recognizes several organizations that are making a difference.

BEAM-101, a genetically modified cell therapy for sickle cell disease (SCD) that’s being tested in clinical trials, has been granted orphan drug status by the U.S. Food and Drug Administration (FDA).